StoneX Group Inc. Buys 1,981 Shares of Cigna Group $CI

Posted by Geri Gentry on Nov 9th, 2026

StoneX Group Inc. raised its stake in Cigna Group (NYSE:CI – Free Report) by 40.5% in the third quarter, HoldingsChannel reports. The institutional investor owned 6,874 shares of the health services provider’s stock after buying an additional 1,981 shares during the quarter. StoneX Group Inc.’s holdings in Cigna Group were worth $1,876,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its position in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after acquiring an additional 840,098 shares during the period. GQG Partners LLC acquired a new stake in shares of Cigna Group in the 2nd quarter worth approximately $1,628,918,000. Bank of America Corp DE grew its holdings in shares of Cigna Group by 8.8% in the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after acquiring an additional 256,677 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Cigna Group by 10.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after acquiring an additional 236,340 shares during the period. Finally, Legal & General Group Plc purchased a new position in Cigna Group in the 2nd quarter valued at approximately $542,779,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CI. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Evercore began coverage on Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target for the company. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Finally, UBS Group reaffirmed a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $335.70.

Read Our Latest Stock Analysis on Cigna Group

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Stock Up 0.0%

Shares of NYSE CI opened at $293.66 on Monday. Cigna Group has a 1 year low of $255.53 and a 1 year high of $318.05. The firm’s 50 day moving average price is $285.81 and its 200 day moving average price is $282.17. The firm has a market cap of $77.60 billion, a P/E ratio of 12.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI – Get Free Report) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping the consensus estimate of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the previous year, the company earned $7.83 EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.62 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is currently 27.54%.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

About Cigna Group

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.